Showing results (1301-1310 of 1,878) with videos related to
Sort By:
Pageof 188
Immunotherapy|April 29, 2015
Cellular immunotherapy with ex vivo expanded cord blood T cells in a humanized mouse model of EBV-associated lymphoproliferative diseaseGo Matsuda, Ken-ichi Imadome, Fuyuko Kawano, et al.Immunotherapy|April 29, 2015
Novel insights into anti-CD40/CD154 immunotherapy in transplant toleranceDavid F Pinelli, Mandy L FordImmunotherapy|March 7, 2023
Low-dose metronomic gemcitabine pretreatments overcome the resistance of breast cancer to immune checkpoint therapyXichen Zheng, Jiajie Kuai, Guanghui ShenImmunotherapy|February 13, 2023
Galectin-9 and PD-L1 antibody blockade combination therapy inhibits tumour progression in pancreatic cancerEnliang Li, Jian Xu, Qi Chen, et al.Immunotherapy|March 6, 2023
Applications and current challenges of chimeric antigen receptor T cells in treating high-grade gliomas in adult and pediatric populationsNicolina Jovanovich, Ahmed Habib, Nu Farrukh Hameed, et al.Immunotherapy|February 28, 2023
Combining in situ vaccination and immunogenic apoptosis to treat cancerArman Kalami, Mehdi Shahgolzari, Ahmad Yari Khosroushahi, et al.Immunotherapy|February 28, 2023
An unusual case of immune-related gastritis in one patient receiving toripalimab therapyXiaoyan Chen, Wenjie ShiImmunotherapy|August 4, 2016
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficienciesMaria Giovanna Danieli, Federica Pulvirenti, Valeria Rocchi, et al.Immunotherapy|November 7, 2022
Safety and efficacy analysis of PD-1 inhibitors in combination with chemotherapy for advanced pancreatic cancerDong Song, Xuejing Yang, Xin Guo, et al.Immunotherapy|June 4, 2020
Tumor-infiltrating lymphocytes as a feasible adjuvant immunotherapy for osteosarcoma with a poor response to neoadjuvant chemotherapyJing Shi, Ming Li, Rongzhi YangPageof 188